SpyGlass Pharma, Inc.
SGP
$24.17
$0.030.12%
NASDAQ
| 12/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.92M | 2.01M | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.63M | 7.75M | |||
| Operating Income | -13.63M | -7.75M | |||
| Income Before Tax | -12.56M | -8.40M | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.56M | -8.40M | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.56M | -8.40M | |||
| EBIT | -13.63M | -7.75M | |||
| EBITDA | -13.41M | -7.65M | |||
| EPS Basic | -5.72 | -4.58 | |||
| Normalized Basic EPS | -3.57 | -2.86 | |||
| EPS Diluted | -5.73 | -4.61 | |||
| Normalized Diluted EPS | -3.57 | -2.86 | |||
| Average Basic Shares Outstanding | 2.20M | 1.83M | |||
| Average Diluted Shares Outstanding | 2.20M | 1.83M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||